Sabrina Blasio - Neptune Wellness Director Communications
| NEPTDelisted Stock | USD 0.13 0.01 7.14% |
Insider
Sabrina Blasio is Director Communications of Neptune Wellness Solutions
| Phone | (450) 687-2262 |
| Web | https://www.neptunecorp.com |
Neptune Wellness Management Efficiency
The company has return on total asset (ROA) of (0.6698) % which means that it has lost $0.6698 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (8.1848) %, meaning that it created substantial loss on money invested by shareholders. Neptune Wellness' management efficiency ratios could be used to measure how well Neptune Wellness manages its routine affairs as well as how well it operates its assets and liabilities.Neptune Wellness Solutions currently holds 25.31 M in liabilities with Debt to Equity (D/E) ratio of 0.27, which may suggest the company is not taking enough advantage from borrowing. Neptune Wellness Sol has a current ratio of 1.67, which is within standard range for the sector. Note, when we think about Neptune Wellness' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Sam Hsing | China Pharma Holdings | N/A | |
| BComm BCom | Akanda Corp | 68 | |
| Benjamin MBA | Esperion Therapeutics | 38 | |
| Eric RPh | Esperion Therapeutics | 52 | |
| Yoshimasa Kyokawa | Shionogi Co Ltd | N/A | |
| Victoria Covel | Sonoma Pharmaceuticals | N/A | |
| Luis Merchan | Flora Growth Corp | 43 | |
| Gang Lai | Universe Pharmaceuticals | 56 | |
| Susumu Mitsumori | Shionogi Co Ltd | N/A | |
| Jean Filippi | Phibro Animal Health | N/A | |
| Lin Yang | Universe Pharmaceuticals | 48 | |
| Eugene III | Biofrontera | 39 | |
| Howard CFA | Im Cannabis Corp | 59 | |
| Ken Gelhaus | Alpha Teknova | 40 | |
| Tejinder Virk | Akanda Corp | 42 | |
| Javier Franco | Flora Growth Corp | 56 | |
| Matthew Lowell | Alpha Teknova | 54 | |
| Erica CPA | Biofrontera | 39 | |
| MD FACC | Esperion Therapeutics | 59 | |
| Matthew Cohen | Flora Growth Corp | 58 | |
| Kohji Hanasaki | Shionogi Co Ltd | N/A | |
Management Performance
| Return On Equity | -8.18 | |||
| Return On Asset | -0.67 |
Neptune Wellness Sol Leadership Team
Elected by the shareholders, the Neptune Wellness' board of directors comprises two types of representatives: Neptune Wellness inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Neptune. The board's role is to monitor Neptune Wellness' management team and ensure that shareholders' interests are well served. Neptune Wellness' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Neptune Wellness' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sabrina Blasio, Director Communications | ||
| Raymond Silcock, Ex CFO | ||
| Melody Harwood, Head Business | ||
| Marc Vaugeois, VP Sales | ||
| Morry Brown, VP Relations | ||
| Roger Corriveau, VicePres Devel | ||
| Paola Patti, Director HR | ||
| Lisa CPA, Interim Officer | ||
| Michael Cammarata, CEO, Director | ||
| Gary Kaminsky, VP Affairs | ||
| Scott Antony, Senior Sales | ||
| Christopher Piazza, Senior Secretary | ||
| John Wirt, Executive Officer | ||
| Jessica Adkins, Sr Communications |
Neptune Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Neptune Wellness a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -8.18 | |||
| Return On Asset | -0.67 | |||
| Profit Margin | (1.37) % | |||
| Operating Margin | (2.33) % | |||
| Current Valuation | 6.14 M | |||
| Shares Outstanding | 4.53 M | |||
| Shares Owned By Insiders | 43.80 % | |||
| Shares Owned By Institutions | 6.09 % | |||
| Number Of Shares Shorted | 25.38 K | |||
| Price To Earning | 23.48 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Neptune Stock
If you are still planning to invest in Neptune Wellness Sol check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neptune Wellness' history and understand the potential risks before investing.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |